Tenet Medicines
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1b/2a in SLE With Budoputug (NCT06570434) | Tenet Medicines | 2025-01-01 |
| Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) (NCT05441826) | Tenet Medicines | 2022-05-03 |
| Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy (NCT04652570) | Tenet Medicines | 2021-05-05 |
Track Tenet Medicines automatically
Every clearance here is in the API, with alerts when new ones post.